About
Dr. Geneviève Huynh-Trudeau is a highly skilled Medical Oncologist and Hematologist, offering expert care in the diagnosis and systemic treatment of both solid tumors and hematologic malignancies. Practicing at Hôpital Charles-Lemoyne in Greenfield Park, QC, she is part of a dedicated healthcare team committed to providing comprehensive cancer care and blood disorder management. Her approach emphasizes personalized treatment strategies, utilizing advanced diagnostic tools and evidence-based therapies to optimize patient outcomes. She adheres to the professional standards set by the Collège des médecins du Québec (CMQ), ensuring the highest quality of care for her patients.
Graduating with a Medical Degree in 2019, Dr. Huynh-Trudeau has been practicing as a Medical Oncologist and Hematologist for over five years. She completed extensive postgraduate training and certification in Medical Oncology and Hematology, specializing in the management of complex cancer cases and blood disorders. Her education has provided her with a broad foundation in both clinical and research aspects of her field, enabling her to stay current with evolving treatment modalities.
Dedicated to multidisciplinary, patient-centered care, Dr. Huynh-Trudeau emphasizes evidence-based treatment plans that incorporate the latest research and guidelines. She is committed to supporting her patients and their families through compassionate communication and comprehensive care coordination. Fluent in French, she ensures clear, empathetic communication with her diverse patient population in Greenfield Park and surrounding areas.
Dr. Geneviève Huynh-Trudeau has expertise in managing a wide range of conditions, including:
Common Cancers (Solid Tumors) Treated
- Prostate Cancer: Cancer developing in the prostate gland in men, with treatment options including hormone therapy, chemotherapy, radiation, or active surveillance.
- Gastrointestinal Cancers (Esophageal, Stomach, Pancreatic, Liver, Biliary): A group of cancers affecting the digestive system organs, each requiring specific diagnostic and multidisciplinary treatment approaches including systemic therapies.
- Ovarian, Uterine (Endometrial), & Cervical Cancers (Gynecologic Oncology - Medical Aspects): Systemic treatment aspects for cancers of the female reproductive system, often in collaboration with gynecologic oncologists or surgeons.
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Von Willebrand Disease & Other Inherited Bleeding Disorders: Genetic conditions that impair the blood's ability to clot effectively, causing prolonged or excessive bleeding.
- Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
- Iron Deficiency Anemia: A common type of anemia caused by insufficient iron, leading to reduced red blood cell production and oxygen-carrying capacity.
Hematologic Malignancies (Blood Cancers) Treated
- Acute Lymphoblastic Leukemia (ALL): A type of cancer of the blood and bone marrow that affects white blood cells called lymphocytes, common in children but also occurs in adults.
- Myelodysplastic Syndromes (MDS): A group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy, mature blood cells.
- Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Geneviève Huynh-Trudeau or your referring physician.
- Therapeutic Apheresis Consultation (e.g., for TTP, plasma exchange indications): Consultation and coordination for procedures that separate components of blood for therapeutic purposes.
- Management of Treatment-Related Side Effects & Toxicities: Proactive and reactive strategies to manage side effects of cancer therapies, including nausea, fatigue, myelosuppression, and neuropathy.
- Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
- Treatment of Various Solid Tumors: Specialized care for a wide range of cancers such as breast, lung (NSCLC, SCLC), colorectal, prostate, melanoma, ovarian, uterine, cervical, bladder, kidney, pancreatic, stomach, esophageal, head & neck (non-surgical aspects), brain tumors (non-surgical aspects), and sarcomas.
- Autologous & Allogeneic Stem Cell Transplant Consultation, Coordination & Post-Transplant Care (as part of a transplant team or referral network): Evaluating eligibility for, coordinating referrals to, and providing follow-up care for patients undergoing stem cell transplantation for hematologic malignancies.
- Management of Clotting Disorders / Thrombophilia (Inherited & Acquired): Diagnosis, anticoagulation therapy, and long-term management for conditions predisposing to abnormal blood clots (e.g., DVT, PE, Factor V Leiden, Antiphospholipid Syndrome).
- Genetic Counseling & Testing Referrals for Hereditary Cancer Syndromes: Assessment of family history and risk factors, and coordination of referrals for genetic counseling and testing for inherited predispositions to cancer (e.g., BRCA).
Note: This list provides a general overview of services offered in Medical Oncology and Hematology (Cancer and Blood Disorders). Treatment plans are highly individualized. Dr. Huynh-Trudeau provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Huynh-Trudeau or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Huynh-Trudeau's practice is primarily based at Hôpital Charles-Lemoyne, situated in the areas near central Greenfield Park. The hospital is easily accessible from local points of interest and is well-served by public transit options. The facility is wheelchair accessible, ensuring ease of access for all patients. Metered street parking is available nearby, providing convenient options for those arriving by car. The hospital's location offers a welcoming environment with modern amenities designed to support patient comfort and care efficiency.
- Are consultations and treatments with Dr. Huynh-Trudeau, an Medical Oncologist and Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Medical Oncologist and Hematologist such as Dr. Huynh-Trudeau are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Huynh-Trudeau's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Huynh-Trudeau, an Medical Oncologist and Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Medical Oncologist and Hematologist like Dr. Huynh-Trudeau for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What is palliative care, and when might Dr. Huynh-Trudeau discuss it?
- Palliative care is specialized medical care focused on providing relief from the symptoms and stress of a serious illness, like cancer or advanced blood disorders. The goal is to improve quality of life for both the patient and the family. It can be provided at any stage of illness, alongside curative treatments, not just at the end of life. Dr. Huynh-Trudeau may discuss palliative care if you are experiencing significant symptoms, to help manage pain, fatigue, nausea, anxiety, or other issues, and to provide an extra layer of support.
- What are common side effects of chemotherapy, and how does Dr. Huynh-Trudeau help manage them?
- Chemotherapy can cause various side effects, which differ depending on the specific drugs used, the dose, and individual patient factors. Common ones include fatigue, nausea, vomiting, hair loss, mouth sores, changes in appetite, diarrhea or constipation, and increased risk of infection due to low blood counts. Dr. Huynh-Trudeau and the oncology nursing team will discuss potential side effects of your specific treatment plan in detail and will actively work to prevent and manage them with medications (e.g., anti-nausea drugs, growth factors to boost blood counts), supportive care advice (nutrition, hydration, rest), and regular monitoring. Open communication about any side effects you experience is very important for effective management.
- Does a Hematologist only treat blood cancers?
- No, Hematologists treat a wide range of blood disorders, not just cancers. This includes benign (non-cancerous) conditions such as various types of anemia (e.g., iron deficiency anemia, vitamin B12 deficiency, sickle cell anemia, thalassemia), bleeding disorders (like hemophilia or von Willebrand disease), clotting disorders (thrombophilia, deep vein thrombosis, pulmonary embolism), and issues with white blood cells (like neutropenia) or platelets (like ITP). Dr. Huynh-Trudeau, if focused on hematology, can diagnose and manage these conditions.
- How will treatment decisions be made for my condition by Dr. Huynh-Trudeau?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Huynh-Trudeau will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
- Why might I need a bone marrow biopsy, and what does it involve if Dr. Huynh-Trudeau recommends it?
- A bone marrow biopsy and aspiration are procedures used to collect and examine bone marrow, the soft tissue inside your bones where blood cells are made. Dr. Huynh-Trudeau might recommend this test to diagnose or monitor various blood disorders, including leukemias, lymphomas, myeloma, anemias, or infections. The procedure is usually done on the back of the hip bone under local anesthesia. A needle is used to withdraw a small sample of liquid marrow (aspiration) and a small core of bone marrow tissue (biopsy). You may feel some pressure or brief pain.
Hôpital Charles-Lemoyne
3120 Bd Taschereau
Greenfield Park, QC J4V 2H1
Phone: (450) 466-5000 | Fax: (450) 466-5066
The facility is wheelchair accessible.
Dr. Huynh-Trudeau is a licensed Medical Oncologist and Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=19926